title: Attenuated vascular reactivity in dogs with anteroventral third ventricle lesions.
abstract: Lesion of the anteroventral portion of the third cerebral ventricle causes hypernatremia, adipsia, and attenuation of the pressor response to intravenous administration of angiotensin II and norepinephrine. In addition, these lesions prevent the development of several experimental models of hypertension. In this study, a lesion of the third cerebral ventricle region was made in 14 dogs. In seven dogs in which hypernatremia developed the lesions included the organum vasculosum of the lamina terminalis; seven animals in which the circumventricular organ was spared by the lesion remained normonatremic. Vascular responsiveness of isolated right carotid artery rings to angiotensin II and phenylephrine was assessed 3 days after lesioning the anteroventral portion of the third cerebral ventricle. In endothelium-denuded ring vessels, vasoconstrictor responses to phenylephrine were significantly decreased in animals both with and without inclusion of the organum vasculosum of the lamina terminalis. A similar effect was observed in intact vessels of dogs in which the circumventricular organ was spared but not in those with lesions that included this area. In contrast, angiotensin II-induced vasoconstriction was significantly decreased in the arteries with intact endothelium of both groups of lesioned animals. These data show that lesion of the anteroventral third ventricle area alters alpha 1-adrenergic and angiotensin II vascular responsiveness in isolated carotid artery rings with the possible participation of the endothelium.
authors.affiliation: Cleveland Clinic Foundation, Ohio.
authors.forename: J M
authors.initials: JM
authors.lastname: Brum
authors.forename: A F
authors.initials: AF
authors.lastname: Tramposch
authors.forename: C H
authors.initials: CH
authors.lastname: Block
authors.forename: F G
authors.initials: FG
authors.lastname: Estafanous
authors.forename: C M
authors.initials: CM
authors.lastname: Ferrario
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D002339:Carotid Arteries / Q000187:drug effects; D002552:Cerebral Ventricles / Q000033:anatomy & histology / Q000502:physiology*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004727:Endothelium / Q000502:physiology; D006400:Hematocrit; D007213:Indomethacin / Q000494:pharmacology; D008297:Male; D010656:Phenylephrine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D014661:Vasoconstriction / Q000187:drug effects; D014882:Water-Electrolyte Balance
chemical_list: D000804:Angiotensin II; D010656:Phenylephrine; D012964:Sodium; D011433:Propranolol; D000109:Acetylcholine; D007213:Indomethacin